Vimarsana
Biggest News Aggregation in the World

Page 22 - Pharma Sector News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Sector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Sector Today - Breaking & Trending Today

Are pharma cos poised for a bull ride? Here's what analysts believe - Vimarsana News

Are pharma cos poised for a bull ride? Here's what analysts believe

Alok Dalal of Jefferies believes the $27 billion domestic pharma industry is well-placed to achieve low double-digit growth in the coming years on increased spending on medicines as the population starts to age.

Drug price challenge - Editorials - Business Recorder - Vimarsana News

Drug price challenge - Editorials - Business Recorder

EDITORIAL: It seems that the government has still not learned that rejecting any increase in prices of medicines to...

Up & Away: These three pharma stocks gave up to 16% returns in 2023; Is there scope for more? - Vimarsana News

Up & Away: These three pharma stocks gave up to 16% returns in 2023; Is there scope for more?

Analysts have identified a common factor among the three firms that prompted investors to lap up their shares — their relatively low valuations over the past few months.

Powerful Women Award 2023 By The Crazy Tales was successfully hosted on March 29, 2023 - Vimarsana News

Powerful Women Award 2023 By The Crazy Tales was successfully hosted on March 29, 2023

New Delhi [India], March 30 (ANI/ATK): The Crazy Tales successfully presented the Powerful Women Award on March 29, 2023, at the Constitution Club of India, New Delhi

Know your stock | Is Eris Lifesciences on the verge of a turnaround? - Vimarsana News

Know your stock | Is Eris Lifesciences on the verge of a turnaround?

Eris Lifesciences has been on an acquisition spree in a bid to diversify its offerings. The company recently bought nine dermatology brands from both Dr Reddy’s Laboratories and Glenmark Pharma.